Altered [3H]quinuclidinyl benzilate binding in the striatum of rats following chronic cholinesterase inhibition with diisopropylfluorophosphate.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D003342:Corpus Striatum / Q000201:enzymology / Q000378:metabolism*; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D010862:Pilocarpine / Q000378:metabolism; D011812:Quinuclidines / Q000378:metabolism*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism*; D051381:Rats; D011976:Receptors, Muscarinic / Q000378:metabolism
D002800:Cholinesterase Inhibitors; D011812:Quinuclidines; D011976:Receptors, Muscarinic; D010862:Pilocarpine; D007531:Isoflurophate; D011813:Quinuclidinyl Benzilate; D000109:Acetylcholine